123 related articles for article (PubMed ID: 26201378)
1. Adalimumab-induced porokeratosis.
Frew JW; Parsi K
Australas J Dermatol; 2015 Aug; 56(3):e80-1. PubMed ID: 26201378
[No Abstract] [Full Text] [Related]
2. Palmoplantar pustulosis by adalimumab in a patient with Crohn disease.
Ortiz Salvador JM; Cubells Sánchez L; Subiabre Ferrer D
Med Clin (Barc); 2016 Dec; 147(12):565. PubMed ID: 27431884
[No Abstract] [Full Text] [Related]
3. Education and imaging. Gastrointestinal: Cutaneous reaction associated with loss of response to adalimumab.
Hillemand CG; Leong RW
J Gastroenterol Hepatol; 2013 Jul; 28(7):1073. PubMed ID: 23782119
[No Abstract] [Full Text] [Related]
4. Acneiform eruption as a probable paradoxical reaction to adalimumab.
Fernández-Crehuet P; Ruiz-Villaverde R
Int J Dermatol; 2015 Aug; 54(8):e306-8. PubMed ID: 24697221
[No Abstract] [Full Text] [Related]
5. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
[No Abstract] [Full Text] [Related]
6. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
7. Eruptive disseminated superficial porokeratosis with rapid resolution: a drug-induced phenomenon?
Goulding JM; Teoh JK; Carr RA; Humphreys F; Gee BC
Clin Exp Dermatol; 2009 Dec; 34(8):895-7. PubMed ID: 19508573
[TBL] [Abstract][Full Text] [Related]
8. Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
el-Azhary RA; Lehman JS
Int J Dermatol; 2016 Apr; 55(4):e214-5. PubMed ID: 26917358
[No Abstract] [Full Text] [Related]
9. Adalimumab-Induced Disseminated Superficial Porokeratosis.
Guarneri C; Cannavò SP; Lentini M; Polimeni G
Ann Pharmacother; 2011 Feb; 45(2):280-1. PubMed ID: 21304021
[No Abstract] [Full Text] [Related]
10. IgA nephropathy onset in a Crohn's disease patient treated with Adalimumab.
Bruzzese V; Lorenzetti R; Rosa M; Di Giulio S; Hassan C; Costas G; Zullo A
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):223-4. PubMed ID: 27091038
[No Abstract] [Full Text] [Related]
11. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
Darrigade AS; Goussot JF; Milpied B; Taieb A; Seneschal J
Eur J Dermatol; 2016 Dec; 26(6):633-634. PubMed ID: 27634463
[No Abstract] [Full Text] [Related]
12. [Adult blaschkitis (lichen striatus) in a patient treated with adalimumab].
Monteagudo B; Cabanillas M; Suárez-Amor O; Ramírez-Santos A; Alvarez JC; de Las Heras C
Actas Dermosifiliogr; 2010 Dec; 101(10):891-2. PubMed ID: 21159267
[No Abstract] [Full Text] [Related]
13. Acne conglobata induced by adalimumab.
Balakirski G; Neis MM; Megahed M
Eur J Dermatol; 2017 Jun; 27(3):320-321. PubMed ID: 28524046
[No Abstract] [Full Text] [Related]
14. Histopathologic findings of drug-induced eruptive porokeratosis under nivolumab therapy.
Magalhães C; Costa M; Campainha S; Coelho A; César A
J Cutan Pathol; 2023 Apr; 50(4):298-300. PubMed ID: 36515632
[No Abstract] [Full Text] [Related]
15. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
[No Abstract] [Full Text] [Related]
17. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
18. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
19. Pulmonary actinomycosis coexisting with intestinal tuberculosis as a complication of adalimumab treatment for Crohn's disease.
Aleric I; Katalinic D; Vcev A; Brinar M
Acta Gastroenterol Belg; 2017; 80(4):544-546. PubMed ID: 29560655
[No Abstract] [Full Text] [Related]
20. Psoriasiform Eruption Secondary to the Use of Adalimumab.
Esteves PM; Barbalho MG; Cortes JG; Cuzzi T; Sodre CT; Ramos-e-Silva M
J Drugs Dermatol; 2015 Oct; 14(10):1152-4. PubMed ID: 26461828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
